State Street’s Viela Bio, Inc. Common Stock VIE Stock Holding History

State Street’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-813,979	Closed	-$29.3M	–	3999
2020 Q4	$29.3M	Sell	813,979 -364,443	-31%	-$12.8M	﹤0.01%	1998
2020 Q3	$33.1M	Buy	1,178,422 +544,396	+86%	+$19.3M	﹤0.01%	1734
2020 Q2	$27.5M	Buy	634,026 +538,575	+564%	+$24.4M	﹤0.01%	1848
2020 Q1	$3.63M	Buy	95,451 +38,047	+66%	+$1.48M	﹤0.01%	2784
2019 Q4	$1.56M	Buy	+57,404	New	+$1.45M	﹤0.01%	3323

State Street's VIE Position: Q1 2021 in Review

State Street sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 813,979 shares — an estimated $29.3M sold.

State Street first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $33.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

State Street reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
State Street sold 813,979 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $29.3M.
State Street first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
State Street's Viela Bio, Inc. Common Stock position peaked at $33.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on State Street's 13F filing for Q1 2021, filed 17 May 2021.